CIS Insulin Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Insulin is one of the essential peptide hormones produced by beta cells in the pancreas. It maintains the metabolism of carbohydrates and fats by promoting glucose absorption from the blood to skeletal muscles and fat tissue and by causing fat to be stored rather than used for energy. Insufficient production of insulin results to accumulation of sugar in blood cells which causes diabetes.

MARKET SCOPE

The

"Global CIS Insulin Market Analysis to 2031"

is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of the CIS insulin market with detailed market segmentation by product, source, application, and geography. The report provides key statistics on the market status of the leading CIS insulin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

•  Based on product, the global CIS insulin market is segmented into rapid acting, long acting, premixed, premixed analog, short acting, intermediate acting.
  
•  On the basis of source, the market is segmented into human recombinant, analogs
  
•  On the basis of application, the market is segmented into type ii diabetes, type i diabetes.
  

MARKET DYNAMICS

Drivers

•   Rise in the incidences of diabetes cases worldwide.
  
•   Rise in the several health disorders due to changing lifestyle.
  

Restraints

•   The strict regulatory requirements for approval of insulin and high cost of insulin are the major restraining factor for this market.
  

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The CIS insulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the CIS insulin market in these regions.

IMPACT OF COVID-19 ON CIS INSULIN MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the CIS insulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from CIS insulin market are anticipated to lucrative growth opportunities in the future with the rising demand for CIS insulin in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the CIS insulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

•  Bristol-Myers Squibb Company,
  
•  Boehringer Ingelheim
  
•  Eli Lilly and Company
  
•  Novo Nordisk
  
•  Sanofi
  
•  Novartis AG
  
•  Pfizer, Inc
  
•  Merck
  
•  Takeda Pharmaceuticals
  
•  Oramed Pharmaceuticals
  

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

CIS Insulin Report Scope